Wang, J.C.; Liu, K.C.; Gettleman, B.S.; Piple, A.S.; Chen, M.S.; Menendez, L.R.; Heckmann, N.D.; Christ, A.B.
Medicare Advantage in Soft Tissue Sarcoma May Be Associated with Worse Patient Outcomes. J. Clin. Med. 2023, 12, 5122.
https://doi.org/10.3390/jcm12155122
AMA Style
Wang JC, Liu KC, Gettleman BS, Piple AS, Chen MS, Menendez LR, Heckmann ND, Christ AB.
Medicare Advantage in Soft Tissue Sarcoma May Be Associated with Worse Patient Outcomes. Journal of Clinical Medicine. 2023; 12(15):5122.
https://doi.org/10.3390/jcm12155122
Chicago/Turabian Style
Wang, Jennifer C., Kevin C. Liu, Brandon S. Gettleman, Amit S. Piple, Matthew S. Chen, Lawrence R. Menendez, Nathanael D. Heckmann, and Alexander B. Christ.
2023. "Medicare Advantage in Soft Tissue Sarcoma May Be Associated with Worse Patient Outcomes" Journal of Clinical Medicine 12, no. 15: 5122.
https://doi.org/10.3390/jcm12155122
APA Style
Wang, J. C., Liu, K. C., Gettleman, B. S., Piple, A. S., Chen, M. S., Menendez, L. R., Heckmann, N. D., & Christ, A. B.
(2023). Medicare Advantage in Soft Tissue Sarcoma May Be Associated with Worse Patient Outcomes. Journal of Clinical Medicine, 12(15), 5122.
https://doi.org/10.3390/jcm12155122